Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted. The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov. Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

NLM Logo

N,N-dicyclopropyl-4-((1,5-dimethyl-1H-pyrazol-3-yl)amino)-6-ethyl-1-methyl-1,6-dihydroimidazo(4,5-d)pyrrolo(2,3b)pyridine-7-carboxamide MeSH Supplementary Concept Data 2025


MeSH Supplementary
N,N-dicyclopropyl-4-((1,5-dimethyl-1H-pyrazol-3-yl)amino)-6-ethyl-1-methyl-1,6-dihydroimidazo(4,5-d)pyrrolo(2,3b)pyridine-7-carboxamide
Unique ID
C571029
RDF Unique Identifier
http://id.nlm.nih.gov/mesh/C571029
Entry Term(s)
BMS-911543
Registry Numbers
0
Heading Mapped to
*Heterocyclic Compounds, 3-Ring
Frequency
9
Note
has antineoplastic activity; structure in first source
Source
Leukemia. 2012 Feb;26(2):280-8.
Indexing Information
Janus Kinase 2
Date of Entry
2012/03/29
Revision Date
2012/03/29
N,N-dicyclopropyl-4-((1,5-dimethyl-1H-pyrazol-3-yl)amino)-6-ethyl-1-methyl-1,6-dihydroimidazo(4,5-d)pyrrolo(2,3b)pyridine-7-carboxamide Preferred
BMS-911543 Narrower
page delivered in 0.019s